Emopamil-binding protein, a mammalian protein that binds a series of structurally diverse neuroprotective agents, exhibits delta8-delta7 sterol isomerase activity in yeast. 1996

S Silve, and P H Dupuy, and C Labit-Lebouteiller, and M Kaghad, and P Chalon, and A Rahier, and M Taton, and J Lupker, and D Shire, and G Loison
Department of Microbiology, Sanofi-Recherche, Labège Innopole BP137, F-31676 Labège Cédex, France.

Delta8-delta7 sterol isomerase is an essential enzyme on the sterol biosynthesis pathway in eukaryotes. This endoplasmic reticulum-resident membrane protein catalyzes the conversion of delta8-sterols to their corresponding delta7-isomers. No sequence data for high eukaryote sterol isomerase being available so far, we have cloned a murine sterol isomerase-encoding cDNA by functional complementation of the corresponding deficiency in the yeast Saccharomyces cerevisiae. The amino acid sequence deduced from the cDNA open reading frame is highly similar to human emopamil-binding protein (EBP), a protein of unknown function that constitutes a molecular target for neuroprotective drugs. A yeast strain in which the sterol isomerase coding sequence has been replaced by that of human EBP or its murine homologue recovers the ability to convert delta8-sterol into delta7-sterol, both in vivo and in vitro. In these recombinant strains, both cell proliferation and the sterol isomerization reaction are inhibited by the high affinity EBP ligand trifluoperazine, as is the case in mammalian cells but not in wild type yeast cell. In contrast, the recombinant strains are much less susceptible to the sterol inhibition effect of haloperidol and fenpropimorph, as compared with wild type yeast strains. Our results strongly suggest that EBP and delta8-delta7 sterol isomerase are identical proteins in mammals.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009025 Morpholines Tetrahydro-1,4-Oxazines,Tetrahydro 1,4 Oxazines
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D002849 Chromatography, Gas Fractionation of a vaporized sample as a consequence of partition between a mobile gaseous phase and a stationary phase held in a column. Two types are gas-solid chromatography, where the fixed phase is a solid, and gas-liquid, in which the stationary phase is a nonvolatile liquid supported on an inert solid matrix. Chromatography, Gas-Liquid,Gas Chromatography,Chromatographies, Gas,Chromatographies, Gas-Liquid,Chromatography, Gas Liquid,Gas Chromatographies,Gas-Liquid Chromatographies,Gas-Liquid Chromatography
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D004268 DNA-Binding Proteins Proteins which bind to DNA. The family includes proteins which bind to both double- and single-stranded DNA and also includes specific DNA binding proteins in serum which can be used as markers for malignant diseases. DNA Helix Destabilizing Proteins,DNA-Binding Protein,Single-Stranded DNA Binding Proteins,DNA Binding Protein,DNA Single-Stranded Binding Protein,SS DNA BP,Single-Stranded DNA-Binding Protein,Binding Protein, DNA,DNA Binding Proteins,DNA Single Stranded Binding Protein,DNA-Binding Protein, Single-Stranded,Protein, DNA-Binding,Single Stranded DNA Binding Protein,Single Stranded DNA Binding Proteins
D006220 Haloperidol A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279) Haldol
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000071230 Transcriptional Regulator ERG A trans-activator and member of the erythroblast transformation-specific family of transcriptions factors that contain a characteristic ETS MOTIF. It is required for PLATELET CELL ADHESION to the subendothelium and associates with CHIMERIC ONCOGENE PROTEINS in PROSTATE CANCER; EWING'S SARCOMA; and ACUTE MYELOID LEUKEMIA. Transforming Protein ERG,V-Ets Avian Erythroblastosis Virus E26 Oncogene Homolog Protein,V-Ets Avian Erythroblastosis Virus E26 Oncogene Related Protein,V Ets Avian Erythroblastosis Virus E26 Oncogene Homolog Protein,V Ets Avian Erythroblastosis Virus E26 Oncogene Related Protein

Related Publications

S Silve, and P H Dupuy, and C Labit-Lebouteiller, and M Kaghad, and P Chalon, and A Rahier, and M Taton, and J Lupker, and D Shire, and G Loison
August 2003, The Biochemical journal,
S Silve, and P H Dupuy, and C Labit-Lebouteiller, and M Kaghad, and P Chalon, and A Rahier, and M Taton, and J Lupker, and D Shire, and G Loison
September 1998, Molecular pharmacology,
S Silve, and P H Dupuy, and C Labit-Lebouteiller, and M Kaghad, and P Chalon, and A Rahier, and M Taton, and J Lupker, and D Shire, and G Loison
November 1998, Plant molecular biology,
S Silve, and P H Dupuy, and C Labit-Lebouteiller, and M Kaghad, and P Chalon, and A Rahier, and M Taton, and J Lupker, and D Shire, and G Loison
August 1969, The Biochemical journal,
S Silve, and P H Dupuy, and C Labit-Lebouteiller, and M Kaghad, and P Chalon, and A Rahier, and M Taton, and J Lupker, and D Shire, and G Loison
October 2013, ACS medicinal chemistry letters,
S Silve, and P H Dupuy, and C Labit-Lebouteiller, and M Kaghad, and P Chalon, and A Rahier, and M Taton, and J Lupker, and D Shire, and G Loison
May 2003, Journal of medicinal chemistry,
S Silve, and P H Dupuy, and C Labit-Lebouteiller, and M Kaghad, and P Chalon, and A Rahier, and M Taton, and J Lupker, and D Shire, and G Loison
July 1989, Proceedings of the National Academy of Sciences of the United States of America,
S Silve, and P H Dupuy, and C Labit-Lebouteiller, and M Kaghad, and P Chalon, and A Rahier, and M Taton, and J Lupker, and D Shire, and G Loison
June 1984, Science (New York, N.Y.),
S Silve, and P H Dupuy, and C Labit-Lebouteiller, and M Kaghad, and P Chalon, and A Rahier, and M Taton, and J Lupker, and D Shire, and G Loison
August 2001, Experimental dermatology,
S Silve, and P H Dupuy, and C Labit-Lebouteiller, and M Kaghad, and P Chalon, and A Rahier, and M Taton, and J Lupker, and D Shire, and G Loison
December 2008, Journal of medicinal chemistry,
Copied contents to your clipboard!